SCHEMBL9140299

SCHEMBL9140299

O=C1C=CC2(CC1)CC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL516008 0.90 ALDH1A1 (0.36)
SCHEMBL13333805 0.90 ALDH1A1 (0.36)
SCHEMBL9449773 0.88 ALDH1A1 (0.34)
SCHEMBL515788 0.88 ALDH1A1 (0.34)
SCHEMBL1373549 0.88 ALDH1A1 (0.34)
SCHEMBL17277743 0.84 NEK2 (0.31)
SCHEMBL3728133 0.84
SCHEMBL4409815 0.83 ALDH1A1 (0.34)
SCHEMBL11956609 0.81 ALOX5 (0.30)
SCHEMBL12087982 0.81 HTR2A (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076354-A Methods of treating migraine with MNK inhibitors 4E治疗公司 2024-05-24 CN disclosed
EP-4363419-A1 SPIROCYCLIC PYRIDINE-1,5-DIONES EXHIBITING MNK INHIBITION AND THEIR METHOD OF USE 4E Therapeutics, Inc. (US) 2024-05-08 EP disclosed
WO-2023278686-A1 SPIROCYCLIC PYRIDINE-1,5-DIONES EXHIBITING MNK INHIBITION AND THEIR METHOD OF USE 4E THERAPEUTICS, INC. (US) 2023-01-05 WO disclosed
US-5471003-A Catalytic hydrogenation then distillation to remove butyraldehyde EASTMAN CHEMICAL COMPANY (US) 1995-11-28 US disclosed